Study of Metalloproteinases in Breast Cancer
Author Information
Author(s): AE Kossakowska, SA Huchcroft, SJ Urbanski, DR Edwards
Primary Institution: University of Calgary
Hypothesis
The balance between metalloproteinases (MMPs) and their inhibitors (TIMPs) is altered in neoplasia, contributing to the invasive properties of malignant tumors.
Conclusion
The study found that MMP-11 and MMP-9 are associated with malignant breast lesions, allowing for a predictive accuracy of 90% in distinguishing between malignant and benign tissues.
Supporting Evidence
- MMP-11 distinguished malignant disease with a predictive accuracy of 84%.
- Detection of either MMP-11 or MMP-9 transcripts increased predictive accuracy to 90%.
- Elevated MMP-9 and TIMP-1 expression was observed in all four tumor systems studied.
Takeaway
This study looked at how certain proteins in breast tissue can help tell if a tumor is cancerous or not, and found that two specific proteins are really good at this.
Methodology
The study analyzed the expression of MMP and TIMP genes in breast tissue samples using Northern blot analysis.
Limitations
The study focused only on mRNA detection and did not assess protein levels, which may not always reflect mRNA expression.
Participant Demographics
The study included 37 breast tissue samples, comprising benign and malignant lesions.
Statistical Information
P-Value
0.0004
Statistical Significance
p=0.0004
Want to read the original?
Access the complete publication on the publisher's website